DK1421389T3 - Neurofibrilmarkører - Google Patents
NeurofibrilmarkørerInfo
- Publication number
- DK1421389T3 DK1421389T3 DK02720102.9T DK02720102T DK1421389T3 DK 1421389 T3 DK1421389 T3 DK 1421389T3 DK 02720102 T DK02720102 T DK 02720102T DK 1421389 T3 DK1421389 T3 DK 1421389T3
- Authority
- DK
- Denmark
- Prior art keywords
- tau
- tau protein
- derivative
- agent
- binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/583—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Lubricants (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0106953.3A GB0106953D0 (en) | 2001-03-20 | 2001-03-20 | Neufofibrillary labels |
PCT/GB2002/001318 WO2002075318A2 (en) | 2001-03-20 | 2002-03-20 | Neurofibrillary labels |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1421389T3 true DK1421389T3 (da) | 2012-08-13 |
Family
ID=9911161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02720102.9T DK1421389T3 (da) | 2001-03-20 | 2002-03-20 | Neurofibrilmarkører |
Country Status (13)
Country | Link |
---|---|
US (3) | US7335652B2 (da) |
EP (1) | EP1421389B1 (da) |
JP (2) | JP4288073B2 (da) |
CN (2) | CN101696977B (da) |
AT (1) | ATE556323T1 (da) |
AU (1) | AU2002251172B2 (da) |
CA (1) | CA2440794C (da) |
DK (1) | DK1421389T3 (da) |
ES (1) | ES2386773T3 (da) |
GB (1) | GB0106953D0 (da) |
HK (1) | HK1062044A1 (da) |
PT (1) | PT1421389E (da) |
WO (1) | WO2002075318A2 (da) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9506197D0 (en) | 1995-03-27 | 1995-05-17 | Hoffmann La Roche | Inhibition of tau-tau association. |
GB0100119D0 (en) | 2001-01-03 | 2001-02-14 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
GB0101049D0 (en) | 2001-01-15 | 2001-02-28 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
GB0106953D0 (en) * | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
GB0113121D0 (en) * | 2001-05-30 | 2001-07-18 | Univ Leeds | Biologically active photosensitisers |
GB0117326D0 (en) | 2001-07-16 | 2001-09-05 | Univ Aberdeen | Napthoquinone-type inhibitors of protein aggregation |
US20050032857A1 (en) * | 2003-06-19 | 2005-02-10 | Jeff Kuret | Methods for inhibiting or reversing tau filament fibrillization |
GB0322756D0 (en) * | 2003-09-29 | 2003-10-29 | Univ Aberdeen | Methods of chemical synthesis |
CN101084204B (zh) | 2004-09-23 | 2012-12-05 | 卫思道制药有限公司 | 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法 |
PL2322517T3 (pl) | 2004-09-23 | 2019-09-30 | Wista Laboratories Ltd. | Sposoby syntezy chemicznej i oczyszczania związków diaminofenotiazyniowych, w tym chlorku metylotioniny (MTC) |
AU2007231126B2 (en) | 2006-03-29 | 2012-11-01 | Wista Laboratories Ltd. | Inhibitors of protein aggregation |
EP2853293B1 (en) * | 2006-03-29 | 2017-11-22 | WisTa Laboratories Ltd. | Thioninium compounds and their use |
PT2013191E (pt) | 2006-03-29 | 2010-10-29 | Wista Lab Ltd | Sais de 3,7-diamino-10h-fenotiazina e a sua utilização |
JP5132090B2 (ja) * | 2006-06-16 | 2013-01-30 | 東和薬品株式会社 | 塩酸エピナスチンドライシロップ剤 |
ES2912571T3 (es) | 2006-07-11 | 2022-05-26 | Wista Lab Ltd | Procedimientos de síntesis y/o de purificación de compuestos de diaminofenotiazinio |
PL2205245T3 (pl) | 2007-10-03 | 2015-12-31 | Wista Lab Ltd | Zastosowanie terapeutyczne diaminofenotiazyn |
WO2009117042A1 (en) * | 2008-03-21 | 2009-09-24 | Adlyfe, Inc. | Use of pyrene to carry non-peptide agents across the blood brain barrier |
EP2268314A2 (en) * | 2008-03-21 | 2011-01-05 | Adlyfe, Inc. | Use of pyrene to carry peptides across the blood brain barrier |
RU2518892C2 (ru) | 2008-09-23 | 2014-06-10 | Виста Лабораториз Лтд. | Лиганды для агрегированных молекул тау-белка |
ES2600278T3 (es) | 2008-12-10 | 2017-02-08 | Wista Laboratories Ltd. | Sales de xantilio 3,6-disustituidas como medicamentos |
US8703952B2 (en) | 2008-12-12 | 2014-04-22 | Wista Laboratories Ltd. | Synthesis of 9-(arylalkyl)-1,2,3,4-tetrahydro-γ-carboline and analogues and intermediates |
CU23844B1 (es) | 2009-04-17 | 2012-10-15 | Ct De Neurociencias De Cuba | Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de alzheimer |
PL2430007T3 (pl) | 2009-05-12 | 2014-07-31 | Wista Lab Ltd | Sposoby chemicznej syntezy związków diaminofenotiazyniowych z zastosowaniem nadsiarczanowych środków utleniających |
US8785434B2 (en) | 2010-04-30 | 2014-07-22 | Prosetta Antiviral Inc. | Antiviral compounds |
US8697708B2 (en) | 2010-09-15 | 2014-04-15 | F. Hoffmann-La Roche Ag | Azabenzothiazole compounds, compositions and methods of use |
RU2013125326A (ru) * | 2010-11-16 | 2014-12-27 | ДжиИ ХЕЛТКЕР ЛИМИТЕД | Гетероциклические соединения в качестве зондов для визуализации tau-патологии |
EP2645994B1 (en) | 2010-11-30 | 2017-11-01 | WisTa Laboratories Ltd. | Formulations comprising methylthioninium chloride |
EP2670434B1 (en) | 2011-01-31 | 2018-12-26 | Tau Bio-Logic Corp. | Treatment of tauopathies |
US9283230B2 (en) | 2011-02-11 | 2016-03-15 | Wista Laboratories Ltd. | Phenothiazine diaminium salts and their use |
EP2699241B1 (en) | 2011-04-20 | 2016-07-27 | Prosetta Antiviral Inc. | Antiviral compounds |
US9464064B2 (en) | 2011-09-07 | 2016-10-11 | University Of Kansas | HCV helicase inhibitors and methods of use thereof |
CN102942537B (zh) * | 2012-11-09 | 2014-07-02 | 浙江大学 | 一种用作pH荧光探针的苯并噻唑-苯胺类化合物及其制备方法 |
US9588129B2 (en) | 2013-03-15 | 2017-03-07 | Amira Medical Technologies Inc. | Methods for analyzing blood to detect diseases associated with abnormal protein aggregation |
US9186361B2 (en) | 2013-03-15 | 2015-11-17 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
WO2014151630A2 (en) | 2013-03-15 | 2014-09-25 | Irm Llc | Compounds and compositions for the treatment of parasitic diseases |
US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
GB201311891D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compound |
GB201311888D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
US10765755B1 (en) | 2013-11-20 | 2020-09-08 | University Of South Florida | Preparation and characterization of methylene blue nanoparticles for Alzheimer's disease and other tauopathies |
RS58053B1 (sr) | 2013-12-19 | 2019-02-28 | Novartis Ag | [1,2,4] triazolo [1,5-a] pirimidin derivati kao proteazomski inhibitori protozoa za tretman parazitskih bolesti kao što je lišmanijaza |
CN107163022B (zh) * | 2016-03-07 | 2021-07-16 | 上海如絮生物科技有限公司 | 一种异喹啉类化合物、其中间体、制备方法和应用 |
KR20230127371A (ko) * | 2016-11-01 | 2023-08-31 | 아비나스 오퍼레이션스, 인코포레이티드 | 타우(Tau)-단백질 표적화 프로탁(PROTAC) 및 관련 사용 방법 |
SE1750924A1 (sv) * | 2017-07-14 | 2018-10-02 | A method for analyzing the 3d structure of biomolecules | |
JP2021512153A (ja) | 2018-01-26 | 2021-05-13 | イエール ユニバーシティ | タンパク質分解のイミド系モジュレーターおよび使用方法 |
US11155609B2 (en) | 2019-04-05 | 2021-10-26 | TauC3 Biologies Limited | Anti-TAUC3 antibodies and uses thereof |
GB201909493D0 (en) | 2019-07-01 | 2019-08-14 | Wista Lab Ltd | Therapeutic interactions |
EP3999182A1 (en) | 2019-07-17 | 2022-05-25 | Arvinas Operations, Inc. | Tau-protein targeting compounds and associated methods of use |
WO2021127443A1 (en) | 2019-12-19 | 2021-06-24 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
GB202010652D0 (en) | 2020-07-10 | 2020-08-26 | Wista Lab Ltd | Anti-tau antibodies |
GB202010620D0 (en) | 2020-07-10 | 2020-08-26 | Wista Lab Ltd | System |
TW202346865A (zh) | 2022-01-12 | 2023-12-01 | 英商Gt創新公司 | 檢定 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2815926A1 (de) * | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
CA1302250C (en) * | 1986-04-04 | 1992-06-02 | Khalid Iqbal | Diagnostic for alzheimer's disease |
US5008099A (en) * | 1987-04-08 | 1991-04-16 | Salutar, Inc. | Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor |
EP0287909B1 (en) * | 1987-04-08 | 1992-09-02 | Salutar, Inc. | Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor |
GB8724412D0 (en) | 1987-10-19 | 1987-11-25 | Medical Res Council | Protein |
FI101344B1 (fi) * | 1988-03-31 | 1998-06-15 | Tanabe Seiyaku Co | Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta |
WO1993001348A1 (en) | 1991-07-10 | 1993-01-21 | Minnesota Mining And Manufacturing Company | Fluorochemical water- and oil- repellent treating compositions |
WO1993003369A1 (en) * | 1991-08-01 | 1993-02-18 | Voorheis Paul H | Diagnostic method for alzheimer's disease |
DK0618968T3 (da) | 1991-12-06 | 2000-04-10 | Max Planck Gesellschaft | Midler til diagnostisering og behandling af Alzheimer's sygdom |
WO1993019143A1 (en) * | 1992-03-17 | 1993-09-30 | Lord Corporation | Colorant-containing electrorheological materials |
US5536761A (en) * | 1992-12-07 | 1996-07-16 | Sakura Color Products Corporation | Water base dye ink composition |
GB9317193D0 (en) | 1993-08-18 | 1993-10-06 | Zeneca Ltd | Method |
EP0778773A1 (en) * | 1994-08-08 | 1997-06-18 | Albert Einstein College Of Medicine Of Yeshiva University | Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes |
DE4430091A1 (de) * | 1994-08-25 | 1996-02-29 | Bayer Ag | Verwendung von N-substituierten Phenothiazinen |
GB9506197D0 (en) * | 1995-03-27 | 1995-05-17 | Hoffmann La Roche | Inhibition of tau-tau association. |
US5697985A (en) * | 1995-06-07 | 1997-12-16 | Bayer Corporation | Process for the preparation storage-stable dye dispersions |
WO1999062548A1 (en) | 1998-06-01 | 1999-12-09 | Advanced Research And Technology Institute | Methods and compositions for diagnosing tauopathies |
JP2000344684A (ja) | 1999-03-26 | 2000-12-12 | Bf Kenkyusho:Kk | ピロニンb類似化合物によるアミロイドが蓄積する疾患の画像診断プローブおよびそれを含む画像診断用組成物 |
JP2000344685A (ja) | 1999-03-26 | 2000-12-12 | Bf Kenkyusho:Kk | アズールa類似化合物によるアミロイドが蓄積する疾患の画像診断プローブおよびそれを含む画像診断用組成物 |
AU767726B2 (en) * | 1999-04-30 | 2003-11-20 | Pfizer Products Inc. | Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease |
WO2001070699A1 (fr) | 2000-03-22 | 2001-09-27 | Bf Research Institute, Inc. | Analogues d'azur a utilises comme sondes dans l'imagerie diagnostique des maladies dues a l'accumulation d'amyloide, et compositions renfermant ces analogues destinees a l'imagerie diagnostique |
ES2536449T3 (es) | 2000-08-24 | 2015-05-25 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Derivados de tioflavina para uso en diagnosis de la enfermedad de Alzheimer |
GB0100119D0 (en) | 2001-01-03 | 2001-02-14 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
GB0101049D0 (en) | 2001-01-15 | 2001-02-28 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
GB0106953D0 (en) * | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
GB0117326D0 (en) | 2001-07-16 | 2001-09-05 | Univ Aberdeen | Napthoquinone-type inhibitors of protein aggregation |
US6953974B2 (en) * | 2003-08-26 | 2005-10-11 | Texas Instruments Incorporated | EEPROM device and method for providing lower programming voltage |
GB0322756D0 (en) | 2003-09-29 | 2003-10-29 | Univ Aberdeen | Methods of chemical synthesis |
PL2322517T3 (pl) | 2004-09-23 | 2019-09-30 | Wista Laboratories Ltd. | Sposoby syntezy chemicznej i oczyszczania związków diaminofenotiazyniowych, w tym chlorku metylotioniny (MTC) |
-
2001
- 2001-03-20 GB GBGB0106953.3A patent/GB0106953D0/en not_active Ceased
-
2002
- 2002-03-20 EP EP02720102A patent/EP1421389B1/en not_active Expired - Lifetime
- 2002-03-20 CA CA2440794A patent/CA2440794C/en not_active Expired - Lifetime
- 2002-03-20 JP JP2002573679A patent/JP4288073B2/ja not_active Expired - Lifetime
- 2002-03-20 CN CN200810185342.XA patent/CN101696977B/zh not_active Expired - Lifetime
- 2002-03-20 CN CN02810291.6A patent/CN1578910A/zh active Pending
- 2002-03-20 DK DK02720102.9T patent/DK1421389T3/da active
- 2002-03-20 PT PT02720102T patent/PT1421389E/pt unknown
- 2002-03-20 WO PCT/GB2002/001318 patent/WO2002075318A2/en active Application Filing
- 2002-03-20 ES ES02720102T patent/ES2386773T3/es not_active Expired - Lifetime
- 2002-03-20 AU AU2002251172A patent/AU2002251172B2/en not_active Expired
- 2002-03-20 AT AT02720102T patent/ATE556323T1/de active
-
2003
- 2003-09-22 US US10/665,008 patent/US7335652B2/en not_active Expired - Lifetime
-
2004
- 2004-05-27 HK HK04103802.8A patent/HK1062044A1/xx not_active IP Right Cessation
-
2008
- 2008-02-25 US US12/071,693 patent/US7713962B2/en not_active Expired - Lifetime
- 2008-09-24 JP JP2008243567A patent/JP2009035566A/ja active Pending
-
2010
- 2010-05-10 US US12/662,887 patent/US8097615B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4288073B2 (ja) | 2009-07-01 |
EP1421389B1 (en) | 2012-05-02 |
EP1421389A2 (en) | 2004-05-26 |
US8097615B2 (en) | 2012-01-17 |
CN101696977B (zh) | 2014-02-19 |
CA2440794C (en) | 2012-05-01 |
PT1421389E (pt) | 2012-07-10 |
WO2002075318A2 (en) | 2002-09-26 |
ATE556323T1 (de) | 2012-05-15 |
US20100285605A1 (en) | 2010-11-11 |
HK1062044A1 (en) | 2004-10-15 |
AU2002251172B2 (en) | 2007-12-06 |
JP2009035566A (ja) | 2009-02-19 |
ES2386773T3 (es) | 2012-08-30 |
CN101696977A (zh) | 2010-04-21 |
WO2002075318A3 (en) | 2004-03-11 |
US20080219929A1 (en) | 2008-09-11 |
US7335652B2 (en) | 2008-02-26 |
CN1578910A (zh) | 2005-02-09 |
JP2004537034A (ja) | 2004-12-09 |
US7713962B2 (en) | 2010-05-11 |
GB0106953D0 (en) | 2001-05-09 |
US20040213736A1 (en) | 2004-10-28 |
CA2440794A1 (en) | 2002-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1421389T3 (da) | Neurofibrilmarkører | |
DE60044977D1 (de) | Cocktail von nukleaseinhibitoren | |
DK1551876T3 (da) | Antistoffer, der binder til celle-associerede ca 125/0722P og fremgangsmåder til anvendelse deraf | |
ATE483825T1 (de) | Zusammensetzungen für die identifizierung von adenoviren | |
CY1111278T1 (el) | Συστημα ασφαλειας | |
WO2005114219A3 (en) | Assays to identify irreversibly binding inhibitors of receptor tyrosine kinases | |
DK1866433T3 (da) | Fremgangsmåde til identifikation af LRRK-2interagerende molekyler og til rensning af LRRK2 | |
DE60223063D1 (de) | C-kit inhibitoren | |
WO2004067728A3 (en) | Methods and systems for the identification of rna regulatory sequences and compounds that modulate their function | |
BRPI0607016A2 (pt) | marcadores polipeptìdicos para o diagnóstico de cáncer de próstata | |
DE602004015953D1 (de) | Festphase immunochromatographische testverfahren | |
DK2005190T3 (da) | Inhibering af gasc1 | |
WO2005033330A3 (en) | Fluorescent probes for use in protein kinase inhibitor binding assay | |
WO2005036169A3 (en) | Fluorescent probes for ribosomes and method of use | |
DK1236047T3 (da) | Fluorescenskorrelationsspektroskopi til identifikation af forbindelse-mål-binding | |
WO2008054354A3 (en) | Assays for s1oo inhibitors | |
DE50115207D1 (de) | Speichervorrichtung, insbesondere zur zwischenlagerung von test-wafern | |
WO2009137837A3 (en) | Neuregulin/erbb signaling and integrin | |
MXPA05010062A (es) | Metodo de deteccion selectiva de ligandos objetivo. | |
DK1121594T3 (da) | Fremgangsmåder til identifikation af hot-spot remanenser af bindende proteiner og små forbindelser som binder til samme | |
WO2004047615A3 (en) | Hemiasterlin affinity probes and their uses | |
DK1799844T3 (da) | Fremgangsmåde til påvisning af mål | |
MY148511A (en) | Neurofibrillary labels | |
WO2004083865A3 (en) | Materials and methods for modulating cell motility | |
WO2005017196A3 (en) | A method for the identification of irs protein kinase inhibitors or agonists |